A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

By afschroeder • August 31, 2025

Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess L, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Demoruelle MK, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis. Arthritis Rheumatol. 2025 Aug 29. doi: 10.1002/art.43366. Epub ahead of print. PMID: 40884017.

Tags: Publications, Rheumatology

Related Posts

Sleep apnea in individuals with spinal cord injury

Sankari A, Aldwaikat A, Habra M, Salloum A, Zeineddine S, Pandya N, Martin JL, Badr MS. Sleep apnea in individuals with spinal cord injury. J[...]

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands

Nerguizian D, Wei Z, Aldrovandi G, Currier J, Eron J, Fischer W, Gandhi R, Hamill M, Hosey L, Javan A, McCarthy C, Nachman S, Valiyaparambil[...]

Efficacy and safety of bridging intravenous thrombolysis before mechanical thrombectomy: A systematic review and meta-analysis

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Alareed A, Ahmed F, Hasan A, Ahmed R, Aized MT, Rafiq S, Fonarow GC, Hassan[...]